{"content":"<li class=\"n-box-item date-title\" data-end=\"1551848399\" data-start=\"1551762000\" data-txt=\"Monday, December 23, 2019\">Tuesday, March  5, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3440105\" data-ts=\"1551828716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVAV\" target=\"_blank\">AVAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440105-aerovironmentplus-10-after-quarterly-earnings-beat-upsized-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AeroVironment +10% after quarterly earnings beat, upsized guidance</a></h4><ul><li>AeroVironment (NASDAQ:<a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a>) <font color=\"green\">+10.3%</font> after-hours following an easy <a href=\"https://seekingalpha.com/news/3439993-aerovironment-beats-0_20-revenue-line\" target=\"_blank\">FQ3 earnings</a> beat with a 38% Y/Y revenue increase as well as improved FY 2019 EPS guidance.</li><li>AVAV says its funded backlog as of the end of Q3 was $132.5M compared to $113.3M as of the prior-year quarter.</li><li>Q3 gross margin rose 67% Y/Y to $30.4M from $18.3M in the year-ago quarter; as a percentage of revenue, gross margin increased to 40% from 33%, due to higher sales volume.</li><li>On Feb. 9, AVAV says it elected to purchase 632.8M yen (~$5.7M) of additional shares of HAPSMobile to increase its ownership in the joint venture to 10% from 5%.</li><li>For FY 2019, AVAV sees EPS of $1.60-$1.80, including a one-time $0.26 gain from a litigation settlement, vs. prior guidance of $1.30-$1.50 and $1.43 analyst consensus estimate, on revenues of $300M-$310M vs. $308.5M consensus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3440105\" data-linked=\"AeroVironment +10% after quarterly earnings beat, upsized guidance\" data-tweet=\"$AVAV - AeroVironment +10% after quarterly earnings beat, upsized guidance https://seekingalpha.com/news/3440105-aerovironmentplus-10-after-quarterly-earnings-beat-upsized-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3440105-aerovironmentplus-10-after-quarterly-earnings-beat-upsized-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440100\" data-ts=\"1551825858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMP\" target=\"_blank\">IMMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440100-immutepplus-11-after-new-data-from-tacti-mel-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immutep +11% after new data from TACTI-mel trial</a></h4><ul>   <li>Australia's Immutep (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited ADR'>IMMP</a>) is <font color=\"green\">up 11.4%</font> after hours in U.S. trading after it announced <a href=\"https://www.immutep.com/files/content/investor/press-release/2019/1907144.pdf\" target=\"_blank\">more mature data</a> from an ongoing TACTI-mel Phase I clinical trial.</li>    <li>That trial is studying its lead product candidate, eftilagimod alpha, in unresectable or metastatic melanoma.</li>    <li>The company's presenting the data in about 15 minutes at the World Immunotherapy Congress in San Diego.</li>    <li>Efti has a very favorable safety profile in doses up to 30 mg administered subcutaneously, and the company notes combination with PD-1 antagonists is feasible without dose limiting toxicity or reaching MTD.</li>    <li>In results from Part B of the study (a six-patient cohort), all patients are high risk with 100% M1c status, 83% elevated LDH and 50% ECOG 1; and it's seen very deep responses, with one patient showing complete disappearance of the target lesions at three months. Treatment is ongoing (six-plus months) in four patients.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3440100\" data-linked=\"Immutep +11% after new data from TACTI-mel trial\" data-tweet=\"$IMMP - Immutep +11% after new data from TACTI-mel trial https://seekingalpha.com/news/3440100-immutepplus-11-after-new-data-from-tacti-mel-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3440100-immutepplus-11-after-new-data-from-tacti-mel-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440098\" data-ts=\"1551825219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440098-amba-avav-and-vslr-among-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMBA, AVAV and VSLR among after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited ADR'>IMMP</a> <font color=\"green\">+12.3%</font>. <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color=\"green\">+7.9%</font>. <a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color=\"green\">+7.5%</font>. <a href='https://seekingalpha.com/symbol/AGS' title='PlayAGS, Inc.'>AGS</a> <font color=\"green\">+4.3%</font>. <a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings'>AFH</a> <font color=\"green\">+4.1%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a> <font color=\"red\">-14.2%</font>. <a href='https://seekingalpha.com/symbol/CDLX' title='Cardlytics, Inc.'>CDLX</a> <font color=\"red\">-11.9%</font>. <a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a> <font color=\"red\">-</font>10.7%. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color=\"red\">-8.9%</font>. <a href='https://seekingalpha.com/symbol/PRMW' title='Primo Water'>PRMW</a> <font color=\"red\">-7.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3440098\" data-linked=\"AMBA, AVAV and VSLR among after hours movers\" data-tweet=\"$IMMP $AMBA $AVAV - AMBA, AVAV and VSLR among after hours movers https://seekingalpha.com/news/3440098-amba-avav-and-vslr-among-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3440098-amba-avav-and-vslr-among-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440097\" data-ts=\"1551825048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLE\" target=\"_blank\">EGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440097-eagle-bulk-shipping-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Bulk Shipping EPS in-line, beats on revenue</a></h4><ul><li>Eagle Bulk Shipping (NASDAQ:<a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a>): Q4 GAAP EPS of $0.09 in-line.</li><li>Revenue of $86.69M (+16.2% Y/Y) <font color=\"green\">beats by $22.01M</font>.</li><li>Shares <font color=\"green\">+3.11%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17434609-eagle-bulk-shipping-inc-reports-fourth-quarter-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3440097\" data-linked=\"Eagle Bulk Shipping EPS in-line, beats on revenue\" data-tweet=\"$EGLE - Eagle Bulk Shipping EPS in-line, beats on revenue https://seekingalpha.com/news/3440097-eagle-bulk-shipping-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3440097-eagle-bulk-shipping-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440095\" data-ts=\"1551824968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBAY\" target=\"_blank\">CBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440095-cymabayminus-4_8-on-proposed-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CymaBay -4.8% on proposed public offering</a></h4><ul>   <li>CymaBay Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics, Inc.'>CBAY</a>) is <font color=\"red\">4.8% lower</font> after hours following a proposed <a href=\"https://seekingalpha.com/pr/17434352-cymabay-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering of shares</a>.</li>    <li>Size and terms weren't yet disclosed; the company will sell all shares in the offering.</li>    <li>Underwriters will get a 30-day option to buy up to an additional 15% of shares at the offering price.</li>    <li>Joint book-runners are Citigroup, Evercore ISI and Cantor Fitzgerald.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3440095\" data-linked=\"CymaBay -4.8% on proposed public offering\" data-tweet=\"$CBAY - CymaBay -4.8% on proposed public offering https://seekingalpha.com/news/3440095-cymabayminus-4_8-on-proposed-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3440095-cymabayminus-4_8-on-proposed-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440093\" data-ts=\"1551824669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZNP\" target=\"_blank\">HZNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440093-horizon-pharmaminus-2_6-after-doj-demand-over-payments-to-pbms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Pharma -2.6% after DOJ demand over payments to PBMs</a></h4><ul>   <li>Horizon Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a>) is <font color=\"red\">off 2.6%</font> in late trading after <a href=\"https://seekingalpha.com/filing/4389341\" target=\"_blank\">noting in a filing</a> that it received a demand from the Justice Dept. related to payments.</li>    <li>The company today got a civil investigative demand over assertions that some payments to pharmacy benefit managers were potentially in violation of the Anti-Kickback Statute.</li>    <li>Those requests concern Duexis, Vimovo and Pennsaid 2%.</li>    <li>\"We intend to cooperate with the investigation,\" the company says, noting that while it thinks payments and programs are in compliance, it can't give assurance around the DOJ investigation or that it won't result in a material adverse effect on the business.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3440093\" data-linked=\"Horizon Pharma -2.6% after DOJ demand over payments to PBMs\" data-tweet=\"$HZNP - Horizon Pharma -2.6% after DOJ demand over payments to PBMs https://seekingalpha.com/news/3440093-horizon-pharmaminus-2_6-after-doj-demand-over-payments-to-pbms?source=tweet\" data-url=\"https://seekingalpha.com/news/3440093-horizon-pharmaminus-2_6-after-doj-demand-over-payments-to-pbms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440063\" data-ts=\"1551823180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440063-valeritas-down-18-after-hours-on-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas down 18% after hours on soft guidance</a></h4><ul><li>Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) is down <font color=\"red\">18%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17434426-valeritas-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 and 2018 results</a> with an outlook that appears to have disappointed investors. Q4 highlights:</li><li>Revenues: $6.9M (+19%); net loss: ($12.4M) (+20.8%); loss/share: (0.20) (+93.5%).</li><li>Prescription growth up 16% yoy, up 26% in targeted accounts but down 4% in non-targeted accounts.</li><li><strong>Q1 guidance</strong>: Revenues: $6.2M - 6.3M versus consensus of $7.5M.</li><li><strong>2019 guidance</strong>: Revenues: $30M - 34M versus consensus of $33.6M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439981-valeritas-misses-0_01-beats-revenue\" target=\"_blank\">Valeritas misses by $0.01, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3440063\" data-linked=\"Valeritas down 18% after hours on soft guidance\" data-tweet=\"$VLRX - Valeritas down 18% after hours on soft guidance https://seekingalpha.com/news/3440063-valeritas-down-18-after-hours-on-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3440063-valeritas-down-18-after-hours-on-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440060\" data-ts=\"1551822970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIL\" target=\"_blank\">SAIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440060-sailpointminus-1_3-on-q4-beats-in-line-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SailPoint -1.3% on Q4 beats, in-line outlook</a></h4><ul><li>Sailpoint Technologies (NYSE:<a href='https://seekingalpha.com/symbol/SAIL' title='SailPoint Technologies'>SAIL</a>) <font color=\"red\">drops 1.3%</font> after hours after Q4 beats with revenue up 19% Y/Y. In-line Q1 guidance has revenue from $59.5M to $61M and EPS of -$0.02 to $0.</li><li>In-line FY19 outlook has revenue from $293M to $299M and EPS from $0.25 to $0.29.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://investors.sailpoint.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17434467-sailpoint-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3440008-sailpoint-technologies-beats-0_19-beats-revenue\" target=\"_blank\">SailPoint Technologies beats by $0.19, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3440060\" data-linked=\"SailPoint -1.3% on Q4 beats, in-line outlook\" data-tweet=\"$SAIL - SailPoint -1.3% on Q4 beats, in-line outlook https://seekingalpha.com/news/3440060-sailpointminus-1_3-on-q4-beats-in-line-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3440060-sailpointminus-1_3-on-q4-beats-in-line-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440042\" data-ts=\"1551821994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMDI\" target=\"_blank\">TMDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440042-titan-medical-launches-equity-offering-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Medical launches equity offering; shares down 2% after hours</a></h4><ul><li>Titan Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a>) initiates a \"best efforts\" <a href=\"https://seekingalpha.com/pr/17434503-titan-medical-announces-overnight-marketed-offering-units\" target=\"_blank\">public offering</a> of Units expected to raise $20M - 25M. Each Unit consists of one common share and warrant to purchase one common share. Prices, volumes and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3440042\" data-linked=\"Titan Medical launches equity offering; shares down 2% after hours\" data-tweet=\"$TMDI - Titan Medical launches equity offering; shares down 2% after hours https://seekingalpha.com/news/3440042-titan-medical-launches-equity-offering-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3440042-titan-medical-launches-equity-offering-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440035\" data-ts=\"1551821662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNFI\" target=\"_blank\">UNFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440035-united-natural-foodsplus-3-supervalu-results-kick-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Natural Foods +3% as Supervalu results kick in</a></h4><ul><li>United Natural Foods (NYSE:<a href='https://seekingalpha.com/symbol/UNFI' title='United Natural Foods, Inc.'>UNFI</a>) <font color=\"green\">rallies 3.3%</font> after topping estimates for a <a href=\"https://seekingalpha.com/pr/17434431-united-natural-foods-inc-reports-second-quarter-fiscal-2019-results\" target=\"_blank\">quarter</a> that included Supervalu results.</li><li>Legacy UNFI revenue was up 18% in the supernatural channel during the quarter. Supermarkets revenue growth was 445% with the Supervalu boost.</li><li>Operating expenses as a percentage of sales fell 43 bps to 12.23% as synergy benefits factored in.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439989-united-natural-foods-beats-0_23-beats-revenue\" target=\"_blank\">United Natural Foods beats by $0.23, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3440035\" data-linked=\"United Natural Foods +3% as Supervalu results kick in\" data-tweet=\"$UNFI - United Natural Foods +3% as Supervalu results kick in https://seekingalpha.com/news/3440035-united-natural-foodsplus-3-supervalu-results-kick-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3440035-united-natural-foodsplus-3-supervalu-results-kick-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440034\" data-ts=\"1551821584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440034-endologix-down-5-after-hours-on-1-10-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix down 5% after hours on 1:10 reverse split</a></h4><ul><li>Endologix (NASDAQ:<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a>) shareholders have OK'd a <a href=\"https://seekingalpha.com/pr/17434382-endologix-announces-approval-reverse-stock-split\" target=\"_blank\">1:10 reverse stock split</a> that was effective at 4:00 pm ET today. Post-split trading commences tomorrow, March 6, at the open.</li><li>Share are down <font color=\"red\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3440034\" data-linked=\"Endologix down 5% after hours on 1:10 reverse split\" data-tweet=\"$ELGX - Endologix down 5% after hours on 1:10 reverse split https://seekingalpha.com/news/3440034-endologix-down-5-after-hours-on-1-10-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3440034-endologix-down-5-after-hours-on-1-10-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440031\" data-ts=\"1551821474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440031-microchip-narrows-q4-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microchip narrows Q4 guidance</a></h4><ul><li>Microchip (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) <a href=\"https://seekingalpha.com/pr/17434472-microchip-technology-narrows-financial-guidance-fourth-quarter-fiscal-2019\" target=\"_blank\">narrows</a> its Q4 guidance to consolidated net sales of $1.279B to $1.375B from the prior $1.251B to $1.403B.</li><li>Non-GAAP EPS is now expected from $1.30 to $1.49 (was: $1.26 to $1.53).</li><li>Key quote: \"We are not able to predict whether inventory at our distributors will increase or decrease and are therefore providing a relatively broad range of revenue guidance.\"</li><li>MCHP is <font color=\"green\">up 0.8%</font> after hours to $87.97.</li></ul><div class=\"tiny-share-widget\" data-id=\"3440031\" data-linked=\"Microchip narrows Q4 guidance\" data-tweet=\"$MCHP - Microchip narrows Q4 guidance https://seekingalpha.com/news/3440031-microchip-narrows-q4-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3440031-microchip-narrows-q4-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440016\" data-ts=\"1551820900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440016-ambarellaplus-3-on-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella +3% on Q4 beats</a></h4><ul><li>Ambarella (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>)<font color=\"green\"> gains 3%</font> after it reports Q4 beats with revenue down 28% Y/Y. Downside Q1 guidance has revenue with 3% of $47M (consensus: $50.2M) with gross margin expected between 58% and 60% and operating expenses from $30.5M to $32.5M.</li><li>Earnings call starts at 4:30 PM ET with a webcast <a href=\"https://www.ambarella.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17434425-ambarella-inc-announces-fourth-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439978-ambarella-beats-0_10-beats-revenue\" target=\"_blank\">Ambarella beats by $0.10, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3440016\" data-linked=\"Ambarella +3% on Q4 beats\" data-tweet=\"$AMBA - Ambarella +3% on Q4 beats https://seekingalpha.com/news/3440016-ambarellaplus-3-on-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3440016-ambarellaplus-3-on-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440014\" data-ts=\"1551820800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTT\" target=\"_blank\">QTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440014-qutoutiaominus-14-after-q4-shows-higher-losses-on-rapid-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qutoutiao -14% after Q4 shows higher losses on rapid growth</a></h4><ul>   <li>Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a>) has <font color=\"red\">dipped 13.7%</font> in early after-hours trading after its Q4 profits missed expectations despite revenue that more than quintupled and topped company guidance.</li>    <li>Revenues rose 426% to 1.327B yuan (about $193M). But net loss swelled to 398M yuan (about $57.9M) from the prior-year loss of 54.6M yuan (non-GAAP net loss widened to 366.7M yuan from 52.4M yuan).</li>    <li>Amid the heavy revenue growth, the company says it's pleased that net loss margin declined thanks to efforts to control user engagement expenses, \"which we expect to continue to decline on a per-DAU basis in the coming quarters.\"</li>    <li>In usage metrics, average daily active users hit 30.9M (up 224% Y/Y and up 45% Q/Q), and average monthly active users reached 93.8M (up 286% Y/Y and 44% Q/Q).</li>    <li>Average daily time spent per DAU hit 63M, nearly double the previous year and up 13% from the previous quarter.</li>    <li>For Q1, it's guiding to net revenue of 1.1B-1.12B yuan. For the full year, it's forecasting revenue of 7.5B-8.5B yuan.</li>    <li><a href=\"https://ir.qutoutiao.net\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439969-qutoutiao-misses-0_03-beats-revenue\" target=\"_blank\">Qutoutiao misses by $0.03, beats on revenue</a> (Mar. 05 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17434371-qutoutiao-inc-reports-fourth-quarter-fiscal-year-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3440014\" data-linked=\"Qutoutiao -14% after Q4 shows higher losses on rapid growth\" data-tweet=\"$QTT - Qutoutiao -14% after Q4 shows higher losses on rapid growth https://seekingalpha.com/news/3440014-qutoutiaominus-14-after-q4-shows-higher-losses-on-rapid-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3440014-qutoutiaominus-14-after-q4-shows-higher-losses-on-rapid-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440005\" data-ts=\"1551820589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRHC\" target=\"_blank\">TRHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440005-tabula-rasa-buys-patient-management-solutions-provider-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tabula Rasa buys patient management solutions provider; shares up 1% after hours</a></h4><ul><li>Tabula Rasa (NASDAQ:<a href='https://seekingalpha.com/symbol/TRHC' title='Tabula Rasa HealthCare'>TRHC</a>) <a href=\"https://seekingalpha.com/pr/17434437-tabula-rasa-healthcare-announces-acquisition-prescribewellness-expanding-medication-risk\" target=\"_blank\">acquires </a>PrescribeWellness &#40;PW&#41;, a cloud-based patient relationship management solutions provider, for an undisclosed sum. The company says PW facilitates collaboration between pharmacies, patients, payers, providers and drugmakers.</li><li><a href=\"https://www.prescribewellness.com/\" target=\"_blank\">PW</a> generated $29M in revenues last year.</li><li>TRHC will host a conference call this afternoon at 5:00 pm ET to discuss the deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3440005\" data-linked=\"Tabula Rasa buys patient management solutions provider; shares up 1% after hours\" data-tweet=\"$TRHC - Tabula Rasa buys patient management solutions provider; shares up 1% after hours https://seekingalpha.com/news/3440005-tabula-rasa-buys-patient-management-solutions-provider-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3440005-tabula-rasa-buys-patient-management-solutions-provider-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3440000\" data-ts=\"1551820556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URBN\" target=\"_blank\">URBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3440000-urban-outfittersplus-3-after-margins-improve\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urban Outfitters +3% after margins improve</a></h4><ul><li>Urban Outfitters (NASDAQ:<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a>) tracks higher after sliding past estimates with its Q4 report.</li><li>Comparable retail segment net sales increased 3% during the quarter, driven by double-digit growth in the digital channel.</li><li>Retail segment sales increased 4% at Free People, 4% at Urban Outfitters and 2% at the Anthropologie Group.</li><li>Wholesale segment net sales increased 3%.</li><li>SG&amp;A expenses as a percentage of sales fell 13 bps compared to a year ago due to the extra sales leverage.</li><li>Adjusted operating margin rose a full point to 33.3% of sales.</li><li>Total inventory was up 5.4% Y/Y at the end of the quarter.</li><li>URBN <font color=\"green\">+2.83%</font> AH to $31.25.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439988-urban-outfitters-beats-0_04-revenue-line\" target=\"_blank\">Urban Outfitters beats by $0.04,  revenue in-line</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3440000\" data-linked=\"Urban Outfitters +3% after margins improve\" data-tweet=\"$URBN - Urban Outfitters +3% after margins improve https://seekingalpha.com/news/3440000-urban-outfittersplus-3-after-margins-improve?source=tweet\" data-url=\"https://seekingalpha.com/news/3440000-urban-outfittersplus-3-after-margins-improve\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439998\" data-ts=\"1551820468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGS\" target=\"_blank\">AGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439998-playags-misses-0_27-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PlayAGS misses by $0.27, beats on revenue</a></h4><ul><li>PlayAGS (NYSE:<a href='https://seekingalpha.com/symbol/AGS' title='PlayAGS, Inc.'>AGS</a>): Q4 GAAP EPS of -$0.29 <span style=\"color:red\">misses by $0.27</span>.</li><li>Revenue of $72.09M (+25.0% Y/Y) <font color=\"green\">beats by $2.43M</font>.</li><li>Shares <font color=\"green\">+5.15%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17434434-ags-announces-fourth-quarter-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3439998\" data-linked=\"PlayAGS misses by $0.27, beats on revenue\" data-tweet=\"$AGS - PlayAGS misses by $0.27, beats on revenue https://seekingalpha.com/news/3439998-playags-misses-0_27-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3439998-playags-misses-0_27-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439992\" data-ts=\"1551820306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOL\" target=\"_blank\">BIOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439992-biolase-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biolase beats by $0.05, beats on revenue</a></h4><ul><li>Biolase (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOL' title='Biolase, Inc.'>BIOL</a>): Q4 Non-GAAP EPS of -$0.13 <span style=\"color:green\">beats by $0.05</span>; GAAP EPS of -$0.33 <span style=\"color:red\">misses by $0.15</span>.</li><li>Revenue of $13.05M (+3.3% Y/Y) <font color=\"green\">beats by $0.04M</font>.</li><li>Shares <font color=\"green\">+1.99%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17434428-biolase-reports-2018-fourth-quarter-full-year-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3439992\" data-linked=\"Biolase beats by $0.05, beats on revenue\" data-tweet=\"$BIOL - Biolase beats by $0.05, beats on revenue https://seekingalpha.com/news/3439992-biolase-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3439992-biolase-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439985\" data-ts=\"1551820150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439985-ross-storesplus-2-after-sales-beat-buybacks-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores +2% after sales beat, buybacks boost</a></h4><ul><li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>) reports comparable sales were up 4% in Q4 after rising 5% a year ago.</li><li>While Ross topped revenue estimates with its Q4 report, a new $2.55B share repurchase program and 13% dividend hike could catch just as much attention.</li><li>Looking ahead, Ross Stores sees full-year EPS of $4.30 to $4.50 vs. $4.50 consensus off comparable sales growth of 1% to 2%.</li><li>Shares of Ross Stores are <font color=\"green\">up 1.75%</font> in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439976-ross-stores-eps-line-beats-revenue\" target=\"_blank\">Ross Stores EPS in-line, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439985\" data-linked=\"Ross Stores +2% after sales beat, buybacks boost\" data-tweet=\"$ROST - Ross Stores +2% after sales beat, buybacks boost https://seekingalpha.com/news/3439985-ross-storesplus-2-after-sales-beat-buybacks-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3439985-ross-storesplus-2-after-sales-beat-buybacks-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439984\" data-ts=\"1551820120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439984-exact-sciences-readies-600m-convertible-debt-offering-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exact Sciences readies $600M convertible debt offering; shares down 2% after hours</a></h4><ul><li>Exact Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a>) <a href=\"https://seekingalpha.com/pr/17434351-exact-sciences-announces-offering-600-million-convertible-senior-notes-due-2027\" target=\"_blank\">commences </a>a public offering of $600M of convertible senior notes due 2027. Price, yield and terms have yet to be released.</li><li>Shares are down <font color=\"red\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439984\" data-linked=\"Exact Sciences readies $600M convertible debt offering; shares down 2% after hours\" data-tweet=\"$EXAS - Exact Sciences readies $600M convertible debt offering; shares down 2% after hours https://seekingalpha.com/news/3439984-exact-sciences-readies-600m-convertible-debt-offering-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3439984-exact-sciences-readies-600m-convertible-debt-offering-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439972\" data-ts=\"1551819945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439972-sarepta-launches-350m-equity-offering-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta launches $350M equity offering; shares down 2% after hours</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) slips <font color=\"red\">2%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17434392-sarepta-therapeutics-announces-proposed-350000-000-public-offering-common-stock\" target=\"_blank\">$350M public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439972\" data-linked=\"Sarepta launches $350M equity offering; shares down 2% after hours\" data-tweet=\"$SRPT - Sarepta launches $350M equity offering; shares down 2% after hours https://seekingalpha.com/news/3439972-sarepta-launches-350m-equity-offering-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3439972-sarepta-launches-350m-equity-offering-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439963\" data-ts=\"1551819596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XXII\" target=\"_blank\">XXII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439963-22nd-century-group-plunges-25-on-gottlieb-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">22nd Century Group plunges 25% on Gottlieb resignation</a></h4><ul><li><a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color=\"red\">-25%</font> on news of the resignation of FDA Commissioner Scott Gottlieb.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439937-altria-philip-morris-higher-gottlieb-resignation\" target=\"_blank\">Altria, Philip Morris higher on Gottlieb resignation</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439963\" data-linked=\"22nd Century Group plunges 25% on Gottlieb resignation\" data-tweet=\"$XXII - 22nd Century Group plunges 25% on Gottlieb resignation https://seekingalpha.com/news/3439963-22nd-century-group-plunges-25-on-gottlieb-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/3439963-22nd-century-group-plunges-25-on-gottlieb-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439953\" data-ts=\"1551818951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPL\" target=\"_blank\">GPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439953-great-panther-completes-beadell-acquisition-changes-name\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Panther completes Beadell acquisition, changes name</a></h4><ul><li>Great Panther Silver (<a href='https://seekingalpha.com/symbol/GPL' title='Great Panther Silver Limited'>GPL</a> <font color='green'>+2.6%</font>) says it completed the acquisition of Beadell Resources and has <a href=\"https://seekingalpha.com/pr/17432849-great-panther-completes-acquisition-beadell\" target=\"_blank\">changed the company's name</a> to Great Panther Mining; the company's NYSE American and Toronto Stock Exchange tickers remain unchanged.</li><li>GPL says the deal \"immediately transforms [it] into an intermediate precious metals producer with a strong and diversified portfolio of producing mines, advanced  stage growth projects and exploration assets,\" adding that combining GPL and Beadell's respective guidance adds ~200K gold equiv. oz. for 2019.</li><li>The company says it will focus on the integration of Brazilian operations, continued optimization of the Tucano gold mine, and advancing an exploration program for Tucano.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439953\" data-linked=\"Great Panther completes Beadell acquisition, changes name\" data-tweet=\"$GPL - Great Panther completes Beadell acquisition, changes name https://seekingalpha.com/news/3439953-great-panther-completes-beadell-acquisition-changes-name?source=tweet\" data-url=\"https://seekingalpha.com/news/3439953-great-panther-completes-beadell-acquisition-changes-name\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439947\" data-ts=\"1551818029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAS\" target=\"_blank\">SEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439947-seaworld-rallies-on-wells-fargo-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaWorld rallies on Wells Fargo confidence</a></h4><ul><li>SeaWorld Entertainment (<a href='https://seekingalpha.com/symbol/SEAS' title='SeaWorld Entertainment Inc.'>SEAS</a> <font color='green'>+2.6%</font>) trades higher Wells Fargo backs up its Outperform rating after reviewing San Diego city revenue data on the company.</li><li>\"Our confidence stems from continued positive monthly San Diego data points, SEAS 2018 deferred revenue +27% at year­end (driven by new season pass programs), and investment/new attractions in each of SEAS major markets, all while the company continues to execute on cost savings/marketing initiatives, deleveraging, and potential return of capital through buybacks,\" observes WF analyst Timothy Conder.</li><li>Wells says it would be a buyer of shares at current levels.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439947\" data-linked=\"SeaWorld rallies on Wells Fargo confidence\" data-tweet=\"$SEAS - SeaWorld rallies on Wells Fargo confidence https://seekingalpha.com/news/3439947-seaworld-rallies-on-wells-fargo-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3439947-seaworld-rallies-on-wells-fargo-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439935\" data-ts=\"1551817601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIB\" target=\"_blank\">BIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439935-fda-commish-gottlieb-quits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Commish Gottlieb quits</a></h4><ul><li>FDA Commissioner Scott Gottlieb, M.D., who, by most accounts, was doing a bang-up job revitalizing the agency, has <a href=\"https://www.washingtonpost.com/health/2019/03/05/fda-commissioner-gottlieb-who-raised-alarms-about-teen-vaping-resigns/?noredirect=on&amp;utm_term=.83fc3f4f85f9\" target=\"_blank\">resigned </a>(effective in about a month) to spend more time with his family. He continued to live in Westport, CT with his wife and three children while commuting to Washington, DC.</li><li>His departure could stall his tobacco and e-cigarettes initiatives considering the White House's anti-regulatory stance, although President Trump liked the Commissioner and did not want to see him leave.</li><li>Biotechs are under modest pressure on the news.</li><li>Selected ETFs: (<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <font color=\"red\">-0.4%</font>), (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color=\"red\">-0.4%</font>), (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color=\"red\">-0.1%</font>), (<a href='https://seekingalpha.com/symbol/GRX' title='The Gabelli Healthcare & Wellness Rx Trust'>GRX</a> <font color=\"green\">+0.3%</font>), (<a href='https://seekingalpha.com/symbol/THW' title='Tekla World Healthcare Fund'>THW</a> <font color=\"green\">+0.1%</font>), (<a href='https://seekingalpha.com/symbol/BME' title='BlackRock Health Sciences Trust'>BME</a> <font color=\"red\">-1%</font>), (<a href='https://seekingalpha.com/symbol/BIS' title='ProShares UltraShort Nasdaq Biotechnology ETF'>BIS</a> <font color=\"green\">+0.3%</font>), (<a href='https://seekingalpha.com/symbol/IXJ' title='iShares Global Healthcare ETF'>IXJ</a> <font color=\"green\">+0.2%</font>), (<a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a> <font color=\"red\">-0.3%</font>), (<a href='https://seekingalpha.com/symbol/CHNA' title='The Loncar China BioPharma ETF'>CHNA</a> <font color=\"green\">+0.7%</font>), (<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>)</li><li>Selected tickers: Altria Group (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color=\"green\">+0.9%</font>), British American Tobacco (<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a> <font color=\"green\">+1.9%</font>), Vape Holdings (<a href='https://seekingalpha.com/symbol/VAPE' title='Vape Holdings, Inc.'>OTCPK:VAPE</a>), VaporBrands (<a href='https://seekingalpha.com/symbol/VAPR' title='VaporBrands International, Inc.'>OTCPK:VAPR</a> <font color=\"red\">-1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439935\" data-linked=\"FDA Commish Gottlieb quits\" data-tweet=\"$BIB $GRX $THW - FDA Commish Gottlieb quits https://seekingalpha.com/news/3439935-fda-commish-gottlieb-quits?source=tweet\" data-url=\"https://seekingalpha.com/news/3439935-fda-commish-gottlieb-quits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>129&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439938\" data-ts=\"1551817467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439938-technology-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a>) <font color=\"green\">+29%</font>. YY (NASDAQ:<a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a>) <font color=\"green\">+14%</font>. The9 Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"green\">+13%</font>. Sogou (NYSE:<a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a>) <font color=\"green\">+12%</font>. Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Intelsat S.A. (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) <font color=\"red\">-16%</font>. China Finance Online (NASDAQ:<a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a>) <font color=\"red\">-15%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd Sponsored ADR'>SFET</a>) <font color=\"red\">-14%</font>. Jianpu Technology (NYSE:<a href='https://seekingalpha.com/symbol/JT' title='Jianpu Technology Inc.'>JT</a>) <font color=\"red\">-10%</font>. NeoPhotonics (NYSE:<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439938\" data-linked=\"Technology - Top 5 Gainers / Losers\" data-tweet=\"$AWSM $YY $NCTY - Technology - Top 5 Gainers / Losers https://seekingalpha.com/news/3439938-technology-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439938-technology-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439936\" data-ts=\"1551817252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439936-cardinal-health-hires-nielsen-for-u-s-analytics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardinal Health hires Nielsen for U.S. analytics</a></h4><ul>   <li>Cardinal Health is going with Nielsen Holdings (<a href=\"http://seekingalpha.com/symbol/NLSN\" target=\"_blank\">NLSN</a> <font color=\"red\">-1.8%</font>) to provide <a href=\"https://seekingalpha.com/pr/17434306-cardinal-health-selects-nielsen-u-s-retail-analytics-provider\" target=\"_blank\">U.S. analytics</a> for market and panel data.</li>    <li>The will mean providing retail market data that supports Cardinal Health's network of retail pharmacy partners.</li>    <li>\"Drugstores continue to be an important and trusted channel for U.S. consumers,\" Nielsen's Jeff Williams notes of a channel that's seen U.S. consumers spending $49B over the latest 52 weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439936\" data-linked=\"Cardinal Health hires Nielsen for U.S. analytics\" data-tweet=\"$NLSN - Cardinal Health hires Nielsen for U.S. analytics https://seekingalpha.com/news/3439936-cardinal-health-hires-nielsen-for-u-s-analytics?source=tweet\" data-url=\"https://seekingalpha.com/news/3439936-cardinal-health-hires-nielsen-for-u-s-analytics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439922\" data-ts=\"1551812825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439922-ferrellgas-partners-and-pedevco-among-energy-materials-gainers-key-energy-services-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferrellgas Partners and PEDEVCO among Energy/Materials gainers; Key Energy Services and Torchlight Energy Resources among losers</a></h4><ul><li><b>Gainers: </b>Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a>) <font color=\"green\">+18%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"green\">+10%</font>. NextDecade (NASDAQ:<a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a>) <font color=\"green\">+10%</font>. Tantech (NASDAQ:<a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a>) <font color=\"green\">+5%</font>. Goodrich Petroleum (NYSEMKT:<a href='https://seekingalpha.com/symbol/GDP' title='Goodrich Petroleum Corp.'>GDP</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-14%</font>. Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"red\">-11%</font>. Denbury Resources (NYSE:<a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a>) <font color=\"red\">-7%</font>. SandRidge Energy (NYSE:<a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a>) <font color=\"red\">-7%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy Inc'>CHAP</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439922\" data-linked=\"Ferrellgas Partners and PEDEVCO among Energy/Materials gainers; Key Energy Services and Torchlight Energy Resources among losers\" data-tweet=\"$FGP $PED $NEXT - Ferrellgas Partners and PEDEVCO among Energy/Materials gainers; Key Energy Services and Torchlight Energy Resources among losers https://seekingalpha.com/news/3439922-ferrellgas-partners-and-pedevco-among-energy-materials-gainers-key-energy-services-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3439922-ferrellgas-partners-and-pedevco-among-energy-materials-gainers-key-energy-services-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439921\" data-ts=\"1551812635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AON\" target=\"_blank\">AON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439921-aon-confirms-mulling-willis-towers-watson-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aon confirms it&#39;s mulling Willis Towers Watson deal</a></h4><ul><li>Aon (<a href='https://seekingalpha.com/symbol/AON' title='Aon Corporation'>AON</a> <font color='red'>-6.6%</font>)<a href=\"https://seekingalpha.com/pr/17434236-aon-announcement-made-irish-regulatory-requirements\" target=\"_blank\"> confirms</a> that it's considering an all-share business combination with Willis Towers Watson (<a href='https://seekingalpha.com/symbol/WLTW' title='Willis Towers Watson Public Limited'>WLTW</a> <font color='green'>+7.6%</font>).</li><li>\"The company emphasizes that, at this point, its evaluation of a potential transaction is at a preliminary stage,\" according to its statement.</li><li>There's no certainty that a transaction will take place, it added.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439868-willis-towers-watson-jumps-merger-talks-reported\" target=\"_blank\">Willis Towers Watson jumps after merger talks reported</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439921\" data-linked=\"Aon confirms it&#39;s mulling Willis Towers Watson deal\" data-tweet=\"$AON $WLTW - Aon confirms it&#39;s mulling Willis Towers Watson deal https://seekingalpha.com/news/3439921-aon-confirms-mulling-willis-towers-watson-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3439921-aon-confirms-mulling-willis-towers-watson-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439920\" data-ts=\"1551812466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439920-ges-culp-sees-negative-cash-flow-in-2019-power-unit-struggles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE&#39;s Culp sees negative cash flow in 2019 as power unit struggles</a></h4><ul><li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color=\"red\">-4.2%</font>) sinks after CEO Larry Culp said the company <a href=\"https://www.wsj.com/articles/ge-sees-organic-revenue-increasing-in-low-to-mid-single-digits-in-2019-11551811380\" target=\"_blank\">expects to see negative cash flow in 2019</a> from its industrial business, mainly due to ongoing weakness in its power unit.</li><li>\"This is a multiyear turnaround in power,\" Culp said. \"I don't want to sugarcoat that in any way, shape or form.\"</li><li>GE also sees organic revenue increasing in the low-to-middle single digits in 2019.</li><li>Culp's comments were made during a <a href=\"https://www.ge.com/investor-relations/sites/default/files/JP_Morgan_Aviation_Transportation_Industrials-GE_Presentation_0.pdf\" target=\"_blank\">presentation</a> at J.P. Morgan\u2019s Aviation, Transportation &amp; Industrials conference.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439920\" data-linked=\"GE&#39;s Culp sees negative cash flow in 2019 as power unit struggles\" data-tweet=\"$GE - GE&#39;s Culp sees negative cash flow in 2019 as power unit struggles https://seekingalpha.com/news/3439920-ges-culp-sees-negative-cash-flow-in-2019-power-unit-struggles?source=tweet\" data-url=\"https://seekingalpha.com/news/3439920-ges-culp-sees-negative-cash-flow-in-2019-power-unit-struggles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>107&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439917\" data-ts=\"1551811859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYBR\" target=\"_blank\">CYBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439917-cyberark-hires-palo-alto-nuance-veterans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CyberArk hires Palo Alto, Nuance veterans</a></h4><ul><li>CyberArk (<a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a> <font color='green'>+1%</font>) <a href=\"https://seekingalpha.com/pr/17433359-cyberark-expands-industry-leading-executive-team\" target=\"_blank\">appoints</a> Rich Wenning as VP of North American sales and Clarence Hinton as SVP of corporate development.</li><li>Wenning most recently worked at Palo Alto Networks as the VP of American Enterprise Accounts.</li><li>Hinton previously served as the SVP of strategy and corporate development at Nuance Communications.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439917\" data-linked=\"CyberArk hires Palo Alto, Nuance veterans\" data-tweet=\"$CYBR - CyberArk hires Palo Alto, Nuance veterans https://seekingalpha.com/news/3439917-cyberark-hires-palo-alto-nuance-veterans?source=tweet\" data-url=\"https://seekingalpha.com/news/3439917-cyberark-hires-palo-alto-nuance-veterans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439915\" data-ts=\"1551811528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439915-fcc-terminates-hearings-over-scuttled-sinclair-tribune-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FCC terminates hearings over scuttled Sinclair-Tribune merger</a></h4><ul>   <li>The FCC has dismissed a Hearing Designation Order related to Sinclair Broadcast Group's (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color=\"green\">+2.4%</font>) termination of a planned acquisition of Tribune Media (NYSE:<a href='https://seekingalpha.com/symbol/TRCO' title='Tribune Media Company'>TRCO</a>).</li>    <li>An administrative law judge of the FCC dismissed the order with prejudice.</li>    <li>\"<a href=\"https://seekingalpha.com/pr/17434224-fcc-dismisses-hearing-designation-order\" target=\"_blank\">We continue to maintain</a> that we were completely candid, transparent and honest with the FCC during its review of our proposed acquisition of Tribune Media,\" Sinclair says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439915\" data-linked=\"FCC terminates hearings over scuttled Sinclair-Tribune merger\" data-tweet=\"$TRCO $SBGI - FCC terminates hearings over scuttled Sinclair-Tribune merger https://seekingalpha.com/news/3439915-fcc-terminates-hearings-over-scuttled-sinclair-tribune-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3439915-fcc-terminates-hearings-over-scuttled-sinclair-tribune-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439910\" data-ts=\"1551810592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439910-geminus-6_4-ceo-expects-negative-industrial-free-cash-flow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE -6.4% as CEO expects negative industrial free cash flow</a></h4><ul>   <li>General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric Company'>GE</a>) has taken a <font color=\"red\">6.4% tumble</font> in recent minutes as CEO Larry Culp says he expects negative industrial free cash flow this year.</li>    <li>Culp is speaking to the JPMorgan investment conference.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439910\" data-linked=\"GE -6.4% as CEO expects negative industrial free cash flow\" data-tweet=\"$GE - GE -6.4% as CEO expects negative industrial free cash flow https://seekingalpha.com/news/3439910-geminus-6_4-ceo-expects-negative-industrial-free-cash-flow?source=tweet\" data-url=\"https://seekingalpha.com/news/3439910-geminus-6_4-ceo-expects-negative-industrial-free-cash-flow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>123&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439909\" data-ts=\"1551810458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439909-edward-jones-cuts-centurylink-to-sell-after-10-k-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edward Jones cuts CenturyLink to Sell after 10-K delay</a></h4><ul>   <li>CenturyLink (NYSE:<a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a>) is lower for the third straight day, <font color=\"red\">down 1.8%</font>, amid a downgrade to Sell by Edward Jones.</li>    <li>That follows the company's move to <a href=\"https://seekingalpha.com/filing/4385102\" target=\"_blank\">delay its 10-K filing</a> as it looks to sort out material weaknesses. Analysts have slashed target prices on the stock over the past few months.</li>    <li>Looking at the delay, SA contributor Michael Boyd writes that while the company doesn't expect a material change to financials, the sell-off is coming as investors begin feeling that the team Jeff Storey brought in from Level 3 <a href=\"https://seekingalpha.com/article/4246252-centurylink-plunges-disclosed-internal-material-weaknesses\" target=\"_blank\">doesn't have a \"proper handle\" on the business</a>.</li>    <li>Issues with fair value measurement of the Level 3 assets are surprising, Boyd says, since the acquisition closed in November 2017 and KPMG remains the hired auditor.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439909\" data-linked=\"Edward Jones cuts CenturyLink to Sell after 10-K delay\" data-tweet=\"$CTL - Edward Jones cuts CenturyLink to Sell after 10-K delay https://seekingalpha.com/news/3439909-edward-jones-cuts-centurylink-to-sell-after-10-k-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3439909-edward-jones-cuts-centurylink-to-sell-after-10-k-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>249&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439905\" data-ts=\"1551809707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALPMY\" target=\"_blank\">ALPMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439905-astellas-teams-up-reform-in-alternate-dosing-of-biologics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Astellas teams up with ReForm in alternate dosing of biologics</a></h4><ul><li>Astellas Pharma (<a href='https://seekingalpha.com/symbol/ALPMY' title='Astellas Pharma, Inc. ADR'>OTCPK:ALPMY</a> <font color=\"green\">+0.9%</font>) will <a href=\"https://seekingalpha.com/pr/17432961-reform-biologics-announces-collaboration-agreement-astellas-pharma-inc\" target=\"_blank\">collaborate </a>with Woburn, MA-based <a href=\"https://reformbiologics.com/\" target=\"_blank\">ReForm Biologics</a> on reformulating its pipeline of biologic therapies to allow for alternative dosing, specifically subcutaneous injection, more efficient manufacturing and longer product life cycles.</li><li>Specifically, the parties will focus on reducing the viscosity of the drugs leveraging ReForm's <a href=\"https://reformbiologics.com/technology/\" target=\"_blank\">know-how</a> in protein-protein and protein-solvent interactions to design excipients (an inactive compound that serves as a vehicle for the drug) that enable injections below the skin or device-assisted administration. Biologics are typically administered via intravenous infusion.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439905\" data-linked=\"Astellas teams up with ReForm in alternate dosing of biologics\" data-tweet=\"$ALPMY $ALPMF - Astellas teams up with ReForm in alternate dosing of biologics https://seekingalpha.com/news/3439905-astellas-teams-up-reform-in-alternate-dosing-of-biologics?source=tweet\" data-url=\"https://seekingalpha.com/news/3439905-astellas-teams-up-reform-in-alternate-dosing-of-biologics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439902\" data-ts=\"1551808740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHMA\" target=\"_blank\">CHMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439902-chiasma-up-15-ahead-of-q4-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chiasma up 15% ahead of Q4 report</a></h4><ul><li>Thinly traded micro cap Chiasma (<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma'>CHMA</a> <font color=\"green\">+14.6%</font>) is up on almost a 6x surge in volume, albeit on turnover of only 374K shares. The stock has rallied <font color=\"green\">36%</font> since last week.</li><li>The company should be reporting Q4 and 2018 results as soon as next week. Consensus Q4 view is a loss/share of ($0.31) but is based on only two analysts.</li><li>A key Q3 milestone is topline data from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03252353?lead=chiasma&amp;phase=2&amp;rank=1\" target=\"_blank\">OPTIMAL</a> study evaluating Mycapssa (octreotide) for the maintenance treatment of adults with <a href=\"https://www.mayoclinic.org/diseases-conditions/acromegaly/symptoms-causes/syc-20351222\" target=\"_blank\">acromegaly</a>, an excessive level of growth hormone in the body that leads to oversized bones, including those in the face, hands and feet. If positive, the company plans to file a U.S. marketing application by year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439902\" data-linked=\"Chiasma up 15% ahead of Q4 report\" data-tweet=\"$CHMA - Chiasma up 15% ahead of Q4 report https://seekingalpha.com/news/3439902-chiasma-up-15-ahead-of-q4-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3439902-chiasma-up-15-ahead-of-q4-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439901\" data-ts=\"1551808566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439901-china-rapid-finance-leads-financial-gainers-china-lending-and-hexindai-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Rapid Finance leads financial gainers; China Lending and Hexindai among losers</a></h4><ul><li><b>Gainers: </b>China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a>) <font color=\"green\">+23%</font>. Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"green\">+13%</font>. Willis Towers Watson Public (NASDAQ:<a href='https://seekingalpha.com/symbol/WLTW' title='Willis Towers Watson Public Limited'>WLTW</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Atlas Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings'>AFH</a>) <font color=\"red\">-58%</font>. China Lending (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) <font color=\"red\">-13%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-10%</font>. Banc of California (NYSE:<a href='https://seekingalpha.com/symbol/BANC' title='Banc of California, Inc.'>BANC</a>) <font color=\"red\">-9%</font>. Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439901\" data-linked=\"China Rapid Finance leads financial gainers; China Lending and Hexindai among losers\" data-tweet=\"$XRF $LYL $WLTW - China Rapid Finance leads financial gainers; China Lending and Hexindai among losers https://seekingalpha.com/news/3439901-china-rapid-finance-leads-financial-gainers-china-lending-and-hexindai-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439901-china-rapid-finance-leads-financial-gainers-china-lending-and-hexindai-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439900\" data-ts=\"1551808401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSS\" target=\"_blank\">DSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439900-midday-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday movers and shakers</a></h4><ul><li><strong>Gainers: </strong>Document Security Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/DSS' title='Document Security Systems, Inc.'>DSS</a>) <font color=\"green\">+57%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"green\">+38%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+30%</font>. China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance Limited'>XRF</a>) <font color=\"green\">+23%</font>. Ctrip.com International (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a>) <font color=\"green\">+21%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"green\">+18%</font>. BioHiTech Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BHTG' title='BioHiTech Global, Inc.'>BHTG</a>) <font color=\"green\">+18%</font>. Tuniu Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a>) <font color=\"green\">+17%</font>. YY (NASDAQ:<a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a>) <font color=\"green\">+17%</font>. The9 Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"green\">+16%</font>.</li> <li><strong>Losers: </strong>Atlas Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings, Inc.'>AFH</a>) <font color=\"red\">-58%</font>. Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corporation'>ADMP</a>) <font color=\"red\">-31%</font>. Barnes &amp; Noble Education (NYSE:<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc.'>BNED</a>) <font color=\"red\">-29%</font>. Psychemedics Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/PMD' title='Psychemedics Corporation'>PMD</a>) <font color=\"red\">-22%</font>. Intelsat S.A. (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) <font color=\"red\">-20%</font>. Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>) <font color=\"red\">-18%</font>. Gaia (NASDAQ:<a href='https://seekingalpha.com/symbol/GAIA' title='Gaia, Inc.'>GAIA</a>) <font color=\"red\">-16%</font>. John Wiley &amp; Sons (NYSE:<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a>) <font color=\"red\">-16%</font>. Chimerix (NASDAQ:<a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix, Inc.'>CMRX</a>) <font color=\"red\">-15%</font>. T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems, Inc.'>TTOO</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439900\" data-linked=\"Midday movers and shakers\" data-tweet=\"$DSS $AWSM $FFHL - Midday movers and shakers https://seekingalpha.com/news/3439900-midday-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439900-midday-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439899\" data-ts=\"1551808395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439899-tyson-foods-gains-after-stephens-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods gains after Stephens nod</a></h4><ul> <li>Tysons Foods (<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='green'>+2.4%</font>) rallies after Stephens picks up coverage on the meat stock with an Overweight rating, calling it a \"protein powerhouse with attractive risk/reward.\"</li> <li>\"We think its diversified product offering, best in class operations and prudent capital allocation strategy position the company to create value for shareholders,\" advises the firm.</li> <li>Stephens assigns a price target of $78 to Tyson. The 52-week high for Tyson is $76.55.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439899\" data-linked=\"Tyson Foods gains after Stephens nod\" data-tweet=\"$TSN - Tyson Foods gains after Stephens nod https://seekingalpha.com/news/3439899-tyson-foods-gains-after-stephens-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3439899-tyson-foods-gains-after-stephens-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439895\" data-ts=\"1551807374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REV\" target=\"_blank\">REV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439895-revlon-crumbles-on-weak-tracking-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revlon crumbles on weak tracking data</a></h4><ul><li>Revlon (<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='red'>-19.8%</font>) slides after Jefferies warns that Nielsen data arrived weak.</li><li>Revlon's brand sales were down 15% for the 4-week tracking period ending on February 23. The sales slide was worse than the drops for Coty and e.l.f. Beauty for the same period.</li><li>Shares of Revlon trade at their lowest level of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439895\" data-linked=\"Revlon crumbles on weak tracking data\" data-tweet=\"$REV - Revlon crumbles on weak tracking data https://seekingalpha.com/news/3439895-revlon-crumbles-on-weak-tracking-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3439895-revlon-crumbles-on-weak-tracking-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439893\" data-ts=\"1551806549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439893-intelsat-skid-deepens-despite-support-for-spectrum-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat skid deepens despite support for spectrum plan</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) is <font color=\"red\">down 19.4%</font> in NYSE trading, accelerating a skid this week even in the face of some positivity from an FCC commissioner.</li>    <li>The agency's Michael O'Rielly suggests to Law360 in an interview that C-band monetization would be the fastest way to free up that spectrum for 5G use.</li>    <li>\"Speed is more important than some kind of windfall,\" O'Rielly tells the publication. \"I'm willing to make that trade.\" And finding that spectrum should overshadow worries that a private sale would benefit \"current incumbents\" who would profit from airwaves, he says. (h/t Bloomberg)</li>    <li>Utilizing mid-band spectrum for 5G deployment by mobile carriers has been a plan advanced by a consortium including Intelsat and SES (<a href=\"http://seekingalpha.com/symbol/SGBAF\" target=\"_blank\">SGBAF</a> <font color=\"red\">-7.5%</font>) along with Intel (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color=\"red\">-0.2%</font>).</li>    <li>Intelsat stock has been buffeted amid reports that President Trump's reelection campaign favors a heavy government role in 5G deployment/management. FCC Chairman Ajit Pai has <a href=\"https://twitter.com/AjitPaiFCC/status/957985619887775744\" target=\"_blank\">been on record opposing</a> any plan for the federal government to build and operate a 5G network.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439893\" data-linked=\"Intelsat skid deepens despite support for spectrum plan\" data-tweet=\"$I $SGBAF $INTC - Intelsat skid deepens despite support for spectrum plan https://seekingalpha.com/news/3439893-intelsat-skid-deepens-despite-support-for-spectrum-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3439893-intelsat-skid-deepens-despite-support-for-spectrum-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439888\" data-ts=\"1551805591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439888-fuwei-films-leads-consumer-gainers-revlon-and-nautilus-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fuwei Films leads consumer gainers; Revlon and Nautilus among the losers</a></h4><ul><li><b>Gainers: </b>Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+24%</font>. Tuniu (NASDAQ:<a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a>) <font color=\"green\">+13%</font>. Turning Point (NYSE:<a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a>) <font color=\"green\">+13%</font>. Veritiv (NYSE:<a href='https://seekingalpha.com/symbol/VRTV' title='Veritiv'>VRTV</a>) <font color=\"green\">+10%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>) <font color=\"red\">-18%</font>. Truett-Hurst (NASDAQ:<a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a>) <font color=\"red\">-10%</font>. Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <font color=\"red\">-6%</font>. Sequential Brands Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439888\" data-linked=\"Fuwei Films leads consumer gainers; Revlon and Nautilus among the losers\" data-tweet=\"$FFHL $TOUR $TPB - Fuwei Films leads consumer gainers; Revlon and Nautilus among the losers https://seekingalpha.com/news/3439888-fuwei-films-leads-consumer-gainers-revlon-and-nautilus-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439888-fuwei-films-leads-consumer-gainers-revlon-and-nautilus-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439886\" data-ts=\"1551805231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439886-western-digital-micron-drop-on-chip-price-headwind\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital, Micron drop on chip price headwind</a></h4><ul><li>Susquehanna says Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) and Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) could face a headwind from DRAM and NAND chip prices that are \"tracking below prior expectations.\"</li><li>Analyst Mehdi Hosseini: \"Even with a more moderate ASP decline in 2H19, margins are not expected to dramatically rebound due to excess inventory accumulated in 1H19 as well as flattening of the cost curves.\"</li><li>The firm expects Micron's outlook \"to fall well short of the consensus\" when it reports Q2 results on March 20. Mic</li><li>Susquehanna maintains Neutral ratings on both and raises Micron's PT from $33 to $35 and WDC's from $40 to $44.</li><li>Related news: DRAMeXchange <a href=\"https://press.trendforce.com/node/view/3217.html\" target=\"_blank\">expects</a> Q1 contract prices to drop nearly 30%, worse than the prior 25% outlook and the highest single-season decline since 2011.</li><li>Micron shares are <font color=\"red\">down 1.7%</font> to $40.36 while WDC <font color=\"red\">drops 2.3%</font> to $51.40.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439886\" data-linked=\"Western Digital, Micron drop on chip price headwind\" data-tweet=\"$MU $WDC $MU - Western Digital, Micron drop on chip price headwind https://seekingalpha.com/news/3439886-western-digital-micron-drop-on-chip-price-headwind?source=tweet\" data-url=\"https://seekingalpha.com/news/3439886-western-digital-micron-drop-on-chip-price-headwind\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>96&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439885\" data-ts=\"1551805170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KKPNY\" target=\"_blank\">KKPNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439885-kpn-dips-dutch-bill-may-scuttle-canadian-buyout-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KPN dips as Dutch bill may scuttle Canadian buyout bid</a></h4><ul>   <li>Dutch telecom leader Royal KPN (<a href=\"http://seekingalpha.com/symbol/KKPNY\" target=\"_blank\">KKPNY</a> <font color=\"red\">-2.5%</font>) is lower in U.S. trading as a bill in the Netherlands looks to affect a proposed leveraged buyout by Canada's Brookfield.</li>    <li>The bill (which could ban or reverse telecom takeovers for reasons of national security or public order) probably \"destroys hopes\" of such a buyout, MainFirst analyst Stephane Beyazian tells Bloomberg.</li>    <li>That has a larger effect on pan-European M&amp;A, Beyazian adds, since it could be expected most European governments have a similar vision on protecting networks and data.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439885\" data-linked=\"KPN dips as Dutch bill may scuttle Canadian buyout bid\" data-tweet=\"$KKPNY $KKPNF - KPN dips as Dutch bill may scuttle Canadian buyout bid https://seekingalpha.com/news/3439885-kpn-dips-dutch-bill-may-scuttle-canadian-buyout-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3439885-kpn-dips-dutch-bill-may-scuttle-canadian-buyout-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439880\" data-ts=\"1551803125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439880-analysts-raise-salesforce-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Salesforce targets after earnings</a></h4><ul><li>Bernstein maintains a Market Perform rating on Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) after <a href=\"https://seekingalpha.com/news/3439632-salesforce-minus-2_6-percent-downside-outlook\" target=\"_blank\">earnings</a> and raises the target from $149 to $160.</li><li>The firm still has long-term concerns about Salesforce's ability to significantly expand margins as it decelerates, but says \"this quarter was another positive data point regarding its growth runway.\"</li><li>More action: UBS maintains a Buy rating and ups the PT from $180 to $190 notes the post-earnings pullback happened because the quarter wasn't the same \"blowout\" seen in the last Q4 report. But the firm sees \"CRM as offering a solid combination of secular growth, stable FCF, and defensible FCF -based valuation support.\"</li><li>CRM shares are <font color=\"red\">down 1.5%</font> to $156.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439880\" data-linked=\"Analysts raise Salesforce targets after earnings\" data-tweet=\"$CRM - Analysts raise Salesforce targets after earnings https://seekingalpha.com/news/3439880-analysts-raise-salesforce-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3439880-analysts-raise-salesforce-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439876\" data-ts=\"1551802192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PMD\" target=\"_blank\">PMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439876-psychemedics-down-20-after-q4-report-risks-in-brazil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Psychemedics down 20% after Q4 report, risks in Brazil</a></h4><ul><li>Thinly traded nano cap Psychemedics (<a href='https://seekingalpha.com/symbol/PMD' title='Psychemedics Corporation'>PMD</a> <font color=\"red\">-19.6%</font>) slumps on a 9x surge in volume following its <a href=\"https://seekingalpha.com/pr/17432642-psychemedics-corporation-announces-3rd-straight-year-record-revenue-declares-90th-consecutive\" target=\"_blank\">Q4 report</a> released after the close yesterday. Highlights:</li><li>Revenues were up 2% to $9.9M, net income down 63% to $643K, EPS down 62% to $0.16.</li><li>The company says its business in Brazil is more uncertain after a healthcare services provider there acquired 55% of its independent distributor Psychemedics Brasil. It is currently in talks about the future of their distribution agreement, which either party may cancel after July. As backup, it is \"exploring additional options\" in the country.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439676-psychemedics-reports-q4-results\" target=\"_blank\">Psychemedics reports Q4 results</a> (March 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439876\" data-linked=\"Psychemedics down 20% after Q4 report, risks in Brazil\" data-tweet=\"$PMD - Psychemedics down 20% after Q4 report, risks in Brazil https://seekingalpha.com/news/3439876-psychemedics-down-20-after-q4-report-risks-in-brazil?source=tweet\" data-url=\"https://seekingalpha.com/news/3439876-psychemedics-down-20-after-q4-report-risks-in-brazil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439874\" data-ts=\"1551801883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439874-roku-devices-add-alexa-voice-control-capability\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku devices add Alexa voice control capability</a></h4><ul>   <li>Roku (<a href=\"http://seekingalpha.com/symbol/ROKU\" target=\"_blank\">ROKU</a> <font color=\"green\">+2%</font>) has added a \"skill\" for Amazon's Alexa-enabled devices to make them <a href=\"https://seekingalpha.com/pr/17433528-roku-devices-can-now-interact-amazon-alexa\" target=\"_blank\">compatible with Roku's hardware</a>.</li>    <li>Owners of Roku streaming players and Roku TVs can now control them using Alexa's voice capabilities.</li>    <li>Users can pause shows, launch streaming channels and search for entertainment; and Roku TV users can change power, volume, inputs and OTA channels using their voices via Alexa.</li>    <li>\"By allowing our customers to choose Alexa, in addition to Roku voice search and controls, and other popular voice assistants, we are strengthening the value Roku offers as a neutral platform in home entertainment,\u201d says Roku's Ilya Asnis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439874\" data-linked=\"Roku devices add Alexa voice control capability\" data-tweet=\"$ROKU - Roku devices add Alexa voice control capability https://seekingalpha.com/news/3439874-roku-devices-add-alexa-voice-control-capability?source=tweet\" data-url=\"https://seekingalpha.com/news/3439874-roku-devices-add-alexa-voice-control-capability\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439872\" data-ts=\"1551801801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLIT\" target=\"_blank\">LLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439872-intrexon-and-dbv-technologies-among-healthcare-gainers-adamas-pharmaceuticals-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intrexon and DBV Technologies among healthcare gainers; Adamas Pharmaceuticals leads the losers</a></h4><ul><li><b>Gainers: </b>Lianluo Smart (NASDAQ:<a href='https://seekingalpha.com/symbol/LLIT' title='Lianluo Smart Limited'>LLIT</a>) <font color=\"green\">+17%</font>. Bionano Genomics (NASDAQ:<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics, Inc.'>BNGO</a>) <font color=\"green\">+17%</font>. Intrexon (NASDAQ:<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corporation'>XON</a>) <font color=\"green\">+12%</font>. DBV Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies S.A.'>DBVT</a>) <font color=\"green\">+10%</font>. Chiasma (NASDAQ:<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corporation'>ADMP</a>) <font color=\"red\">-33%</font>. Psychemedics (NASDAQ:<a href='https://seekingalpha.com/symbol/PMD' title='Psychemedics Corporation'>PMD</a>) <font color=\"red\">-20%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"red\">-15%</font>. T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems, Inc.'>TTOO</a>) <font color=\"red\">-15%</font>. Organogenesis Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc.'>ORGO</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439872\" data-linked=\"Intrexon and DBV Technologies among healthcare gainers; Adamas Pharmaceuticals leads the losers\" data-tweet=\"$LLIT $BNGO $XON - Intrexon and DBV Technologies among healthcare gainers; Adamas Pharmaceuticals leads the losers https://seekingalpha.com/news/3439872-intrexon-and-dbv-technologies-among-healthcare-gainers-adamas-pharmaceuticals-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439872-intrexon-and-dbv-technologies-among-healthcare-gainers-adamas-pharmaceuticals-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439870\" data-ts=\"1551801393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNGO\" target=\"_blank\">BNGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439870-bionano-genomics-up-12-on-positive-saphyr-study-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bionano Genomics up 12% on positive Saphyr study data</a></h4><ul><li>Ultra-thinly traded Bionano Genomics (<a href='https://seekingalpha.com/symbol/BNGO' title='Bionano Genomics'>BNGO</a> <font color=\"green\">+12%</font>) is up on almost an 18x surge in volume, albeit on turnover of only 139K shares, in response to <a href=\"https://seekingalpha.com/pr/17433272-largest-study-conducted-bionano-s-platform-date-reveals-never-seen-human-genomic-structural\" target=\"_blank\">results </a>from a genome analysis study using its <a href=\"https://bionanogenomics.com/technology/platform-technology/\" target=\"_blank\">Saphyr </a>platform. The data were just published in <em>Nature Communications</em>.</li><li>Researchers analyzed the genomic structural variations in 154 people using the Bionano system, finding 8.5x more large insertions and 35% more large deletions in the same samples previously reported by the 1000 Genomes Project using short-read sequencing.</li><li>The company says the findings highlight the shortcomings in the current practice of personalized medicine considering the high number of variations, adding that studies like this can be performed on Saphyr for $500 per sample in just four weeks of data collection.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439870\" data-linked=\"Bionano Genomics up 12% on positive Saphyr study data\" data-tweet=\"$BNGO - Bionano Genomics up 12% on positive Saphyr study data https://seekingalpha.com/news/3439870-bionano-genomics-up-12-on-positive-saphyr-study-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3439870-bionano-genomics-up-12-on-positive-saphyr-study-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439869\" data-ts=\"1551801286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439869-target-ceo-says-all-clicking\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target CEO says it&#39;s all clicking</a></h4><ul> <li>Transactions growth underpinned the big quarter for Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color=\"green\">+3.7%</font>) and helped to spark today's rally.</li> <li>Overall transactions were up 5.3% in Q4 on top of 3.6% growth last year during the holiday quarter. The average transaction amount was 0.8% higher.</li> <li>Target CEO Brian Cornell was on <a href=\"https://www.cnbc.com/video/2019/03/05/target-ceo-interview-brian-cornell-earnings-revenue-eps-profits.html\" target=\"_blank\">CNBC</a> this morning to discuss what's going right for the retailer.</li> <li>Cornell: \"Our new small formats in places like New York are being well received. The investments in our own brands are driving market share gains in many important categories. But I think importantly the investments we made in fulfillment are connecting with the consumer. They're taking advantage of ordering online and picking up in store. They're driving into our parking lots. There are ship shoppers now taking advantage of same-day delivery. So, all of those elements are coming together.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439729-target-plus-3-percent-strong-holiday-quarter-comp\" target=\"_blank\">Target +3% after strong holiday quarter comp</a> (March 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439869\" data-linked=\"Target CEO says it&#39;s all clicking\" data-tweet=\"$TGT - Target CEO says it&#39;s all clicking https://seekingalpha.com/news/3439869-target-ceo-says-all-clicking?source=tweet\" data-url=\"https://seekingalpha.com/news/3439869-target-ceo-says-all-clicking\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439866\" data-ts=\"1551800444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEAF\" target=\"_blank\">LEAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439866-leaf-group-responds-to-osmium-call-for-sale-process\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leaf Group responds to Osmium call for sale process</a></h4><ul>   <li>Leaf Group (<a href=\"http://seekingalpha.com/symbol/LEAF\" target=\"_blank\">LEAF</a> <font color=\"red\">-3.1%</font>) has responded to a call from its No. 3 shareholder to <a href=\"https://seekingalpha.com/news/3439604-leaf-group-minus-3_8-percent-3-holder-presses-sale\" target=\"_blank\">pursue a sale of the company</a>, saying it's been in dialogue over the issue and will keep up conversation.</li>    <li>The company's <a href=\"https://seekingalpha.com/pr/17433671-leaf-group-comments-letter-osmium-partners\" target=\"_blank\">been in \"ongoing discussions\"</a> with Osmium Partners over the past four months and will continue to evaluate the talks.</li>    <li>The business is currently on track, Leaf says, with an audience of more than 54M and growing revenue at 20%, and having returned to adjusted EBITDA profitability.</li>    <li>\"We also anticipate further operating leverage in the future as we focus on both organic and inorganic growth opportunities,\" the company says. \"Our Board is committed to acting in the best interests of all of our shareholders and regularly considers a full range of strategic options to enhance shareholder value.\u201d</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439866\" data-linked=\"Leaf Group responds to Osmium call for sale process\" data-tweet=\"$LEAF - Leaf Group responds to Osmium call for sale process https://seekingalpha.com/news/3439866-leaf-group-responds-to-osmium-call-for-sale-process?source=tweet\" data-url=\"https://seekingalpha.com/news/3439866-leaf-group-responds-to-osmium-call-for-sale-process\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439864\" data-ts=\"1551800113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTOO\" target=\"_blank\">TTOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439864-t2-bio-down-7-on-bearish-wdr-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T2 Bio down 7% on bearish WDR report</a></h4><ul><li>T2 Biosystems (<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color=\"red\">-6.8%</font>) is down on almost double normal volume on the heels of a <a href=\"https://seekingalpha.com/article/4246254-hospitals-buying-t2-biosystems-diagnostic-system-1_50-1-year-price-target\" target=\"_blank\">bearish report</a> published on Seeking Alpha from White Diamond Research &#40;WDR&#41;.</li><li>WDR questions the potential of its T2Dx instrument and its recently launched T2Bacteria test, pointing out that hospitals are not embracing the system due to its cost and lack of impact on clinical practice for treating systemic infections.</li><li>WDR also cites the company's modest sales results and the fact that research revenue is outpacing product revenue. It has a $1.50 (63% downside risk) fair value target on the stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439864\" data-linked=\"T2 Bio down 7% on bearish WDR report\" data-tweet=\"$TTOO - T2 Bio down 7% on bearish WDR report https://seekingalpha.com/news/3439864-t2-bio-down-7-on-bearish-wdr-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3439864-t2-bio-down-7-on-bearish-wdr-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439862\" data-ts=\"1551800033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439862-ibm-red-hat-receive-doj-request-dealreporter-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, Red Hat receive DoJ request - DealReporter (update)</a></h4><ul><li>IBM (<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> <font color=\"red\">-0.4%</font>) and Red Hat (<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color=\"red\">-0.4%</font>) have received a second request from the Justice Department, according to Bloomberg headlines citing DealReporter.</li><li>The pending $34B acquisition still faces regulatory scrutiny on antitrust concerns ahead of the planned closing in the second half.</li><li>Update with IBM's statement: \"As IBM has announced previously, we expect the deal to close in the second half of 2019.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3439862\" data-linked=\"IBM, Red Hat receive DoJ request - DealReporter (update)\" data-tweet=\"$IBM $RHT - IBM, Red Hat receive DoJ request - DealReporter (update) https://seekingalpha.com/news/3439862-ibm-red-hat-receive-doj-request-dealreporter-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3439862-ibm-red-hat-receive-doj-request-dealreporter-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439860\" data-ts=\"1551799411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439860-intelminus-1_4-on-new-security-issue-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel -1.4% on new security issue report</a></h4><ul><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) has another major security issue on its hands, according to <a href=\"https://www.theregister.co.uk/2019/03/05/spoiler_intel_flaw/\" target=\"_blank\">The Register</a> citing a new research paper from the Worcester Polytechnic Institute and the University of Lübeck.</li><li>Intel CPUs back to the first-gen Core CPUs have a shortcoming that can be exploited through a foothold like malicious JavaScript in a browser or system malware. The attacker can then access passwords, keys, and other data from the memory.</li><li>The new route exploits the same speculative execution process that enabled last year's <a href=\"https://seekingalpha.com/news/3321016-intel-responds-security-flaw-report-intc-trims-losses-amd-cuts-gains-updated\" target=\"_blank\">Spectre vulnerabilities</a>. Speculative execution lets a process work on future tasks that could be needed while waiting for other computations to finish.</li><li>The researchers didn't find similar behavior in Arm and AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-0.3%</font>) processor cores.</li><li>Researchers are calling the new vulnerability SPOILER. The experts say Intel can't use software mitigation to fully fix the exploits. One author says he doesn't expect Intel to patch the issue within the next five years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439860\" data-linked=\"Intel -1.4% on new security issue report\" data-tweet=\"$INTC $INTC $AMD - Intel -1.4% on new security issue report https://seekingalpha.com/news/3439860-intelminus-1_4-on-new-security-issue-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3439860-intelminus-1_4-on-new-security-issue-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>179&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439859\" data-ts=\"1551799321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439859-cowen-sees-stalling-trends-for-eas-apex-legends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen sees stalling trends for EA&#39;s &#39;Apex Legends&#39;</a></h4><ul>   <li>Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) is <font color=\"red\">1.7% lower</font> this morning after Cowen suggests a rapid ascent in new battle-royale game <i>Apex Legends</i> may have stalled out.</li>    <li>Gamer interest has dropped 50% since launch week, the firm says, pointing to Twitch trends that showed viewership dropping to 132,345 from 271,218. For the most recent week, that means it's fallen behind <i>Fortnite,</i> which surged to 149,897 viewers from 114,631. (h/t <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a>)</li>    <li>On the other hand, bullish Baird sees upside for Q4 and 2020 in the game's player growth. Assuming $20 average revenue per user and 50M active players, <i>Apex Legends</i> would join <i>Fortnite</i> as the only free-to-play titles to top $1B in grosses in their first 12 months, analyst Colin Sebastian says. He has a $106 price target, implying 11% upside.</li>    <li>The game <a href=\"https://seekingalpha.com/news/3439557-eas-apex-legends-races-50m-player-mark\" target=\"_blank\">hit the 50M-player mark</a> yesterday after less than 30 days of release, faster than <i>Fortnite</i> to the milestone.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439859\" data-linked=\"Cowen sees stalling trends for EA&#39;s &#39;Apex Legends&#39;\" data-tweet=\"$EA - Cowen sees stalling trends for EA&#39;s &#39;Apex Legends&#39; https://seekingalpha.com/news/3439859-cowen-sees-stalling-trends-for-eas-apex-legends?source=tweet\" data-url=\"https://seekingalpha.com/news/3439859-cowen-sees-stalling-trends-for-eas-apex-legends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439854\" data-ts=\"1551798780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNED\" target=\"_blank\">BNED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439854-textbook-pain-sends-barnes-noble-education-down-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Textbook pain sends Barnes &amp; Noble Education down 30%</a></h4><ul> <li>Barnes &amp; Noble Education (NYSE:<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc'>BNED</a>) is <font color=\"red\">down 29.8%</font> after the company drops full-year guidance following a weaker-than-anticipated Q3 earnings report.</li> <li>The company now <a href=\"https://seekingalpha.com/pr/17433361-barnes-and-noble-education-reports-third-quarter-2019-financial-results\" target=\"_blank\">sees</a> full-year revenue of $2.15B to $2.20B vs. $2.2B to $2.3B prior.</li> <li>\"The acceleration from physical textbooks to digital offerings contributed to somewhat higher than expected declines in revenue and EBITDA at BNC and MBS,\" observes Barnes &amp; Noble Education CEO Michael Husbey on the quarter.</li><li>The company is accelerating its digital platform in response.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439804-barnes-and-noble-education-reports-q3-results\" target=\"_blank\">Barnes &amp; Noble Education reports Q3 results</a> (March 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439854\" data-linked=\"Textbook pain sends Barnes &amp; Noble Education down 30%\" data-tweet=\"$BNED - Textbook pain sends Barnes &amp; Noble Education down 30% https://seekingalpha.com/news/3439854-textbook-pain-sends-barnes-noble-education-down-30?source=tweet\" data-url=\"https://seekingalpha.com/news/3439854-textbook-pain-sends-barnes-noble-education-down-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439851\" data-ts=\"1551797983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439851-wiley-slides-after-profits-decline-and-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wiley slides after profits decline and miss</a></h4><ul>   <li>John Wiley &amp; Sons (<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a> <font color=\"red\">-9.9%</font>, <a href='https://seekingalpha.com/symbol/JW.B' title='John Wiley & Sons Inc.'>JW.B</a> <font color=\"red\">-2.1%</font>) has slipped out of today's open after missing profit expectations with its fiscal Q3 report.</li>    <li>Revenue dropped 1% on a GAAP basis and operating income fell 23%.</li>    <li>In constant currency, adjusted revenue ticked up 1% and operating income dropped 21%.</li>    <li>Revenue growth in Research (1%) and Solutions (25%) were offset by a drop in Publishing (-14%).</li>    <li>In Publishing, Education Publishing fell 23% and STM and Professional Publishing fell 20%. Meanwhile Test Preparation and Certification rose 23% and WileyPLUS rose 7%.</li>    <li>For 2019, it's trimming guidance for cash from operations, which it now expects to decline in the mid-teens (vs. previous guidance for a high-single-digit drop). It continues to expect flat revenues and a mid-single-digit decline in adjusted EPS.</li>    <li><a href=\"https://edge.media-server.com/m6/p/v7pc4sbn\" target=\"_blank\">Conference call</a> to come at 10 a.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439789-john-wiley-and-sons-misses-0_17-beats-revenue\" target=\"_blank\">John Wiley &amp; Sons misses by $0.17, beats on revenue</a> (Mar. 05 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17433175-wiley-reports-third-quarter-fiscal-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3439851\" data-linked=\"Wiley slides after profits decline and miss\" data-tweet=\"$JW.A $JW.B - Wiley slides after profits decline and miss https://seekingalpha.com/news/3439851-wiley-slides-after-profits-decline-and-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3439851-wiley-slides-after-profits-decline-and-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439850\" data-ts=\"1551797976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439850-citi-cools-on-monster-beverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi cools on Monster Beverage</a></h4><ul> <li>Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a> <font color='red'>-2%</font>) trades lower after being clipped from the U.S. Focus List at Citigroup due largely to valuation.</li> <li>Shares of Monster have piled up a 30% YTD gain.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3439850\" data-linked=\"Citi cools on Monster Beverage\" data-tweet=\"$MNST - Citi cools on Monster Beverage https://seekingalpha.com/news/3439850-citi-cools-on-monster-beverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3439850-citi-cools-on-monster-beverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439831\" data-ts=\"1551795821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIT\" target=\"_blank\">XBIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439831-xbiotech-up-4-premarket-on-positive-bermekimab-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XBiotech up 4% premarket on positive bermekimab data</a></h4><ul><li>XBiotech (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a>) is up <font color=\"green\">4%</font> premarket, albeit on only 600 shares, on the heels of <a href=\"https://seekingalpha.com/pr/17433325-phase-2-clinical-trial-bermekimab-shows-potential-new-standard-care-treatment-hidradenitis\" target=\"_blank\">positive results</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03512275?lead=xbiotech&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating bermekimab in patients with a chronic inflammatory skin disorder called <a href=\"https://www.mayoclinic.org/diseases-conditions/hidradenitis-suppurativa/symptoms-causes/syc-20352306\" target=\"_blank\">hidradenitis suppurativa</a> &#40;HS&#41;, first <a href=\"https://seekingalpha.com/news/3416375-xbiotechs-bermekimab-successful-mid-stage-dermatitis-study\" target=\"_blank\">reported </a>in late January. The data were presented at the American Academy of Dermatology Annual Meeting in Washington, DC.</li><li>42 HS patients received weekly injections of bermekimab for 12 weeks. 63% of patients who had failed to adequately respond to anti-TNF therapy achieved Hidradenitis Suppurativa Clinical Response (HiSCR), the accepted clinical measure of HS severity. 61% of patients who had not received anti-TNF therapy achieved HiSCR. The number of abscesses and inflammatory nodules were reduced 46% and 60%, respectively, in the two groups.</li><li><a href=\"http://www.xbiotech.com/clinical/dermatology.php\" target=\"_blank\">Bermekimab </a>(MABp1) is a monoclonal antibody that binds to (inhibits) the pro-inflammatory protein interleukin-1alpha (IL-1α).</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439831\" data-linked=\"XBiotech up 4% premarket on positive bermekimab data\" data-tweet=\"$XBIT - XBiotech up 4% premarket on positive bermekimab data https://seekingalpha.com/news/3439831-xbiotech-up-4-premarket-on-positive-bermekimab-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3439831-xbiotech-up-4-premarket-on-positive-bermekimab-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439830\" data-ts=\"1551795676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439830-vodafone-plans-4b-in-convertible-debt-for-liberty-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone plans \u20ac4B in convertible debt for Liberty deal</a></h4><ul>   <li>Vodafone (NASDAQ:<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>) will issue \u20ac4B worth of mandatory convertible bonds in order to finance its acquisition of Liberty Global assets.</li>    <li>That's upsized from previous reports for a <a href=\"https://seekingalpha.com/news/3439542-bloomberg-vodafone-plans-3b-convertible-bond-sale-shares-minus-2_8-percent\" target=\"_blank\">planned \u20ac3B sale</a>.</li>    <li>The offering will come in two tranches, maturing no later than March 2021 and March 2022, and it offers a way for Vodafone to finance its deal (to acquire Liberty assets in Germany, the Czech Republic, Hungary and Romania) without adding debt.</li>    <li>Vodafone plans to account for the bonds as equity beyond coupon payments.</li>    <li>Shares are <font color=\"green\">up 3.1%</font> premarket in U.S. trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439830\" data-linked=\"Vodafone plans \u20ac4B in convertible debt for Liberty deal\" data-tweet=\"$VOD - Vodafone plans \u20ac4B in convertible debt for Liberty deal https://seekingalpha.com/news/3439830-vodafone-plans-4b-in-convertible-debt-for-liberty-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3439830-vodafone-plans-4b-in-convertible-debt-for-liberty-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439829\" data-ts=\"1551795457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439829-chinese-customs-holding-up-model-3s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese customs holding up some Model 3s</a></h4><ul> <li>Customs officials in Shanghai are reportedly holding 1.6K Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) Model 3 vehicles due to a <a href=\"https://www.caixinglobal.com/2019-03-05/china-is-currently-holding-1600-teslas-at-customs-101388002.html\" target=\"_blank\">lack</a> of legal product labels.</li> <li>Beijing-based Caixin reports that China's General Administration of Customs found that some vehicles had no Chinese labels on brake fluid tanks and others demonstrated a real motor capacity that differed from the one on the label.</li><li>Issues with Chinese customs isn't a highly unusual issue for U.S. automakers.</li> <li>Shares of Tesla are <font color=\"red\">down 1.64%</font> premarket to $280.50 after a <a href=\"https://seekingalpha.com/news/3439807-tesla-apple-barclays\" target=\"_blank\">biting price target cut</a> from Barclays earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439829\" data-linked=\"Chinese customs holding up some Model 3s\" data-tweet=\"$TSLA - Chinese customs holding up some Model 3s https://seekingalpha.com/news/3439829-chinese-customs-holding-up-model-3s?source=tweet\" data-url=\"https://seekingalpha.com/news/3439829-chinese-customs-holding-up-model-3s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>123&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439828\" data-ts=\"1551795414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFH\" target=\"_blank\">AFH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439828-afh-htz-and-wb-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AFH, HTZ and WB among premarket losers</a></h4><ul><li>Atlas Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings, Inc.'>AFH</a>) <font color=\"red\">-49%</font> on <a href=\"https://seekingalpha.com/news/3439627-atlas-financial-holdings-eps-3_48\" target=\"_blank\">Q4 earnings</a>.</li><li>Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corporation'>ADMP</a>) <font color=\"red\">-31%</font> on slow <a href=\"https://seekingalpha.com/news/3439756-adamas-pharma-29-percent-premarket-slow-gocovri-ramp-downgrades\" target=\"_blank\">Gocovri</a> ramp.</li><li>China Finance Online (NASDAQ:<a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a>) <font color=\"red\">-12%</font>.</li><li>China Lending (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) <font color=\"red\">-11%</font>.</li><li>USA Technologies USAT <font color=\"red\">-11%</font> on <a href=\"https://seekingalpha.com/news/3439659-usa-tech-minus-9_5-percent-delisting-notice\" target=\"_blank\">delisting notice</a>.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"red\">-7%</font>.</li><li>China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-7%</font>.</li><li>Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) <font color=\"red\">-7%</font> after Icahn <a href=\"https://seekingalpha.com/news/3439767-hertz-global-minus-3-percent-icahn-trims-stake\" target=\"_blank\">trims</a> stake.</li><li>Invitae (NYSE:<a href='https://seekingalpha.com/symbol/NVTA' title='Invitae Corporation'>NVTA</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3439631-invitae-launches-125m-equity-offering-shares-4-percent-hours\" target=\"_blank\">launching</a> $125M equity offering.</li><li>GNC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3439727-gnc-holdings-misses-0_16-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>) <font color=\"red\">-6%</font> after pursuing <a href=\"https://seekingalpha.com/news/3439586-uniti-minus-5_3-percent-pursues-credit-amendment-affecting-dividend\" target=\"_blank\">credit amendment</a>.</li><li>SINA (NASDAQ:<a href='https://seekingalpha.com/symbol/SINA' title='SINA Corporation'>SINA</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3439707-sina-misses-0_06-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Weibo (NASDAQ:<a href='https://seekingalpha.com/symbol/WB' title='Weibo Corporation'>WB</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3439706-weibo-beats-0_05-revenue-line\" target=\"_blank\">Q4 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439828\" data-linked=\"AFH, HTZ and WB among premarket losers\" data-tweet=\"$AFH $ADMP $JRJC - AFH, HTZ and WB among premarket losers https://seekingalpha.com/news/3439828-afh-htz-and-wb-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439828-afh-htz-and-wb-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439826\" data-ts=\"1551795282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439826-tgt-kss-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TGT, KSS among premarket gainers</a></h4><ul><li>The9 (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"green\">+43%</font>.</li><li>Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a>) <font color=\"green\">+36%</font>.</li><li>Document Security Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/DSS' title='Document Security Systems, Inc'>DSS</a>) <font color=\"green\">+31%</font> on <a href=\"https://seekingalpha.com/pr/17433083-document-security-systems-inc-signs-exclusive-master-distributor-agreement\" target=\"_blank\">signing</a> an exclusive Master Distributor Agreement with Advanced Cyber Security.</li><li>Ideanomics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDEX' title='Ideanomics Inc'>IDEX</a>) <font color=\"green\">+25%</font> on acquisition <a href=\"https://seekingalpha.com/news/3439816-ideanomics-plus-30-percent-acquisition-news\" target=\"_blank\">news</a>.</li><li>JMU (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"green\">+13%</font>.</li><li>Ctrip.com (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3439672-ctrip-com-beats-0_16-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3439779-cowen-sees-94-percent-upside-aurora-cannabis-premarket-analyst-action\" target=\"_blank\">positive</a> analyst news.</li><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+8%</font>.</li><li>GreenSky (NASDAQ:<a href='https://seekingalpha.com/symbol/GSKY' title='GreenSky'>GSKY</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3439745-greensky-beats-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+6%</font>.</li><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+6%</font>.</li><li>HUYA (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3439679-huya-broadcasting-beats-0_06-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3439724-target-beats-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Kohl's (NYSE:<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3439737-kohls-beats-0_06-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439826\" data-linked=\"TGT, KSS among premarket gainers\" data-tweet=\"$NCTY $AWSM $DSS - TGT, KSS among premarket gainers https://seekingalpha.com/news/3439826-tgt-kss-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3439826-tgt-kss-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439818\" data-ts=\"1551794375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGN\" target=\"_blank\">ALGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439818-align-tech-to-close-stores-april-3-material-charge-this-quarter-shares-down-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Align Tech to close stores by April 3, material charge this quarter; shares down 3% premarket</a></h4><ul><li>Align Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a>) has come out on the <a href=\"https://seekingalpha.com/pr/17433347-arbitration-decision-sdc-entities-requires-align-close-invisalign-stores\" target=\"_blank\">short end</a> of an arbitration ruling involving a dispute with entities associated with SDC Financial LLC over its Invisalign Stores, first piloted in November 2017 and subsequently expanded to 12 locations, that the company is using to educate consumers on Invisalign and connect them with dentists who offer the teeth alignment system.</li><li>Citing the breach of a non-compete provision with SDC Entities, including the misuse of confidential information and violation of fiduciary duties, the arbitrator ruled that the company must close all stores by April 3. It also ordered Align to tender its SDC Financial LLC membership interests to the SDC Entities at a price equal to the capital balance as of October 31, 2017, which Align says is \"significantly below\" its current value. No financial damages were awarded.</li><li>Align's existing supply agreement with SDC remains in place through this year.</li><li>The company expects to record a charge this quarter related to the issue, adding that revenues should not be materially impacted.</li><li>Shares are down <font color=\"red\">3%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439818\" data-linked=\"Align Tech to close stores by April 3, material charge this quarter; shares down 3% premarket\" data-tweet=\"$ALGN - Align Tech to close stores by April 3, material charge this quarter; shares down 3% premarket https://seekingalpha.com/news/3439818-align-tech-to-close-stores-april-3-material-charge-this-quarter-shares-down-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3439818-align-tech-to-close-stores-april-3-material-charge-this-quarter-shares-down-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439817\" data-ts=\"1551794334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LB\" target=\"_blank\">LB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439817-l-brandsplus-4-on-separation-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">L Brands +4% on separation buzz</a></h4><ul> <li>L Brands (NYSE:<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>) is now <font color=\"green\">up 3.55%</font> in premarket action to $27.75 as investors digest Barington Capital's suggestion for a Bath &amp; Body Works IPO or Victoria's Secret spinoff.</li> <li>RBC Capital is already doing the math on a L Brands separation, saying a sum-of-the-parts valuation comes in at $44 per share (+50% upside). The 52-week high for L Brands is $45.54.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3439754-barington-pushes-l-brands-bath-and-body-works-ipo\" target=\"_blank\">Barington pushes L Brands for Bath &amp; Body Works IPO</a> (March 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439817\" data-linked=\"L Brands +4% on separation buzz\" data-tweet=\"$LB - L Brands +4% on separation buzz https://seekingalpha.com/news/3439817-l-brandsplus-4-on-separation-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3439817-l-brandsplus-4-on-separation-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439809\" data-ts=\"1551793510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439809-kla-raises-q3-outlook-after-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLA raises Q3 outlook after acquisition</a></h4><ul><li>KLA (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA Corporation'>KLAC</a>) <a href=\"https://seekingalpha.com/pr/17433372-kla-provides-updated-financial-guidance-mid-quarter-completion-orbotech-acquisition\" target=\"_blank\">updates</a> its Q3 guidance to include the mid-quarter completion of its Orbotech acquisition.</li><li>Q3 revenue is now expected from $1.025B to $1.115B (was: $880M to $960M). Non-GAAP EPS increases to $1.45 to $1.79 from the prior $1.39 to $1.71.</li><li>KLAC shares are <font color=\"green\">up 1%</font> pre-market to $118.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439809\" data-linked=\"KLA raises Q3 outlook after acquisition\" data-tweet=\"$KLAC - KLA raises Q3 outlook after acquisition https://seekingalpha.com/news/3439809-kla-raises-q3-outlook-after-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3439809-kla-raises-q3-outlook-after-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439807\" data-ts=\"1551793332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439807-tesla-is-no-apple-barclays\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla is no Apple - Barclays</a></h4><ul> <li>Barclays shifts into reverse again on Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>), taking its price target on the EV automaker to <a href=\"https://www.cnbc.com/2019/03/05/tesla-is-no-apple-after-cutting-prices-closing-stores-barclays-warns.html\" target=\"_blank\">$192</a> from $210.</li> <li>\"Much of the bull narrative has rested on Tesla being the next Apple, selling high-volume EVs at premium price point and at high gross margins, in part aided by a unique branded retail presence \u2013 a narrative we see as undermined by the recent price cuts and closing of most of the stores,\" warns analyst Brian Johnson.</li> <li>Johnson and team see the sooner than anticipated announcement of a $35K Model 3 reflecting the need to replenish cash after the convertible repayment, perhaps exacerbated by the weak first two months of U.S. sales.</li> <li>Barclays isn't the first to point out the painful impact on margins of the cheaper Model 3 in comparison to some of the high-flying expectations of the past.</li> <li>Shares of Tesla are <font color=\"red\">down 1.59%</font> in premarket action to $280.63.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439807\" data-linked=\"Tesla is no Apple - Barclays\" data-tweet=\"$TSLA - Tesla is no Apple - Barclays https://seekingalpha.com/news/3439807-tesla-is-no-apple-barclays?source=tweet\" data-url=\"https://seekingalpha.com/news/3439807-tesla-is-no-apple-barclays\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>181&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439802\" data-ts=\"1551792878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNK\" target=\"_blank\">GNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439802-gencoplus-4-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genco +4% after earnings topper</a></h4><ul> <li>Genco Shipping &amp; Trading (NYSE:<a href='https://seekingalpha.com/symbol/GNK' title='Genco Shipping & Trading Limited'>GNK</a>) is <font color=\"green\">up 4.29%</font> after the company cruises past Q4 estimates.</li> <li>The company recorded EBITDA of $44.4M during the quarter on a TCE improvement of 23% Y/Y to $13,237.</li><li>Genco ended the year with a cash position of $203M.</li><li>CEO update: \"So far in 2019, seasonal factors coupled with events such as the Vale dam tragedy have led to volatility in freight rates in the short-term. We believe such short-term volatility highlights the importance of our solid liquidity position as well as our approach of deploying a fleet with direct exposure to the major and minor drybulk commodities both of which present strong long-term demand prospects underpinned by a backdrop of low net fleet growth.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439757-genco-shipping-beats-0_13-beats-revenue\" target=\"_blank\">Genco Shipping beats by $0.13, beats on revenue</a> (March 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439802\" data-linked=\"Genco +4% after earnings topper\" data-tweet=\"$GNK - Genco +4% after earnings topper https://seekingalpha.com/news/3439802-gencoplus-4-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3439802-gencoplus-4-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439801\" data-ts=\"1551792712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439801-ebix-raises-quarterly-goals-expects-acquisitions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix raises quarterly goals; expects acquisitions</a></h4><ul><li>Ebix (NASDAQ:<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a>)<a href=\"https://seekingalpha.com/pr/17433085-ebix-announces-aspirational-quarterly-annualized-revenue-goal-three-quarters-billion-q4-2019\" target=\"_blank\"> announces</a> an \"aspirational\" revenue goal of $750M quarterly annualized revenue by Q4 2019, up from the prior goal of $650M.</li><li>The EBITDA goal is 34% or higher. Ebix reported $45.5M EBITDA in Q4 2018.</li><li>Ebix says it's working on a \"few\" acquisitions it expects to add to EPS and revenue.</li><li>EBIX is <font color=\"green\">up 4.2%</font> pre-market to $55.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439801\" data-linked=\"Ebix raises quarterly goals; expects acquisitions\" data-tweet=\"$EBIX - Ebix raises quarterly goals; expects acquisitions https://seekingalpha.com/news/3439801-ebix-raises-quarterly-goals-expects-acquisitions?source=tweet\" data-url=\"https://seekingalpha.com/news/3439801-ebix-raises-quarterly-goals-expects-acquisitions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439800\" data-ts=\"1551792614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439800-delta-reaffirms-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta reaffirms profit guidance</a></h4><ul> <li>Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) posts an update ahead of the company's presentation at the JPMorgan Aviation, Transportation &amp; Industrials Conference today.</li> <li>The airline company says it's on track to deliver on its Q1 margin and EPS guidance ($6 to $7 vs. $6.53 consensus). For the full year, Delta expects to see 4% to 6% revenue growth and $8B in operating cash flow.</li> <li>Delta management says its running the industry's \"best operation\" with the highest completion factor since the merger. Unit cost growth is benefiting from strong costs controls and a higher completion factor. Delta accelerated buybacks in Q1 to $1.3B, funded by a short-term loan to be repaid by the end of the year.</li> <li><a href=\"https://seekingalpha.com/filing/4388150\" target=\"_blank\">SEC Form 8-K</a></li> <li>Shares of Delta are <font color=\"green\">up 1.46%</font> in premarket trading to $49.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439800\" data-linked=\"Delta reaffirms profit guidance\" data-tweet=\"$DAL - Delta reaffirms profit guidance https://seekingalpha.com/news/3439800-delta-reaffirms-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3439800-delta-reaffirms-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439797\" data-ts=\"1551792370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLEX\" target=\"_blank\">LLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439797-lilis-energy-recapitalizes-balance-sheet-raises-borrowing-base\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilis Energy recapitalizes balance sheet, raises borrowing base</a></h4><ul><li>Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"red\">-3.7%</font> pre-market after announcing a \"<a href=\"https://seekingalpha.com/pr/17432905-lilis-energy-announces-significant-balance-sheet-recapitalization\" target=\"_blank\">significant balance sheet recapitalization</a>.\"</li><li>LLEX says it will exchange its outstanding second lien term loan for a combination of preferred and common stock, and has increased the borrowing base under its revolving credit facility to $125M.</li><li>\"This transaction importantly removes any concerns over leverage and near-term debt maturities,\" says Chairman and CEO Ronald Ormand.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439797\" data-linked=\"Lilis Energy recapitalizes balance sheet, raises borrowing base\" data-tweet=\"$LLEX - Lilis Energy recapitalizes balance sheet, raises borrowing base https://seekingalpha.com/news/3439797-lilis-energy-recapitalizes-balance-sheet-raises-borrowing-base?source=tweet\" data-url=\"https://seekingalpha.com/news/3439797-lilis-energy-recapitalizes-balance-sheet-raises-borrowing-base\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439783\" data-ts=\"1551791914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNVC\" target=\"_blank\">NNVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439783-nanoviricides-reports-positive-early-stage-data-on-broad-spectrum-drug-candidate-shares-up-45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NanoViricides reports positive early-stage data on broad-spectrum drug candidate; shares up 45% premarket</a></h4><ul> <li>NanoViricides' (NYSEMKT:<a href='https://seekingalpha.com/symbol/NNVC' title='NanoViricides, Inc.'>NNVC</a>) has <a href=\"https://seekingalpha.com/pr/17433008-nanoviricides-reports-excellent-safety-profile-first-drug-candidate-dermal-treatment-study\" target=\"_blank\">successfully</a> completed the first safety/toxicology studies evaluating broad-spectrum drug candidate NV-HHV-101, a topical cream formulation, in mini-pigs.  All dose levels were well-tolerated with no safety signals observed.</li><li>Shingles rash will be the first targeted indication for the product.</li>                     <li>Shares are up <font color=\"green\">45%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3439783\" data-linked=\"NanoViricides reports positive early-stage data on broad-spectrum drug candidate; shares up 45% premarket\" data-tweet=\"$NNVC - NanoViricides reports positive early-stage data on broad-spectrum drug candidate; shares up 45% premarket https://seekingalpha.com/news/3439783-nanoviricides-reports-positive-early-stage-data-on-broad-spectrum-drug-candidate-shares-up-45?source=tweet\" data-url=\"https://seekingalpha.com/news/3439783-nanoviricides-reports-positive-early-stage-data-on-broad-spectrum-drug-candidate-shares-up-45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439779\" data-ts=\"1551790548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACB\" target=\"_blank\">ACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439779-cowen-sees-94-upside-in-aurora-cannabis-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen sees 94% upside in Aurora Cannabis in premarket analyst action</a></h4><ul><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) initiated with Outperform rating and $14 (94% upside) price target at Cowen and Company citing its large cultivation footprint and geographic diversity. Shares up <font color=\"green\">3%</font> premarket.</li><li>Gossamer Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/GOSS' title='Gossamer Bio'>GOSS</a>) initiated with Overweight rating and $27 (18% upside) price target at Barclays.</li><li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) resumed with Buy rating and $10 (181% upside) price target at Jefferies. Shares up <font color=\"green\">8%</font> premarket.</li><li>DiaMedica Therapeutics (<a href='https://seekingalpha.com/symbol/DMAC' title='DiaMedica Therapeutics'>DMAC</a>) initiated with Buy rating and $9 (165% upside) price target at Lake Street.</li><li>CTI BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a>) initiated with Buy rating and $4 (236% upside) price target at Lake Street.</li><li>Alnylam Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) upgraded to Overweight with a $122 (44% upside) price target at Morgan Stanley citing the upside with Onpattro. Shares up <font color=\"green\">5%</font> premarket.</li><li>ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) upgraded to Equal Weight with a $3 (15% upside) price target at Morgan Stanley on the heels of a failed Phase 3 study of mirvetuximab soravtansine in ovarian cancer. Shares up <font color=\"green\">3% </font>premarket.</li><li>Evoke Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a>) downgraded to Neutral at H.C. Wainwright citing the multi-disciplinary review letter received from the FDA related to its Gimoti application, citing certain deficiencies. The agency's action date remains April 1. Shares up <font color=\"green\">2%</font> premarket.</li><li>Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMS' title='Adamas Pharmaceuticals, Inc.'>ADMS</a>) downgraded to Market Perform at SVB Leerink. Shares down <font color=\"red\">34%</font> premarket on concerns with the Gocovri launch.</li><li>Endo International (NASDAQ:<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) downgraded to Market Perform at SVB Leerink.</li></ul><div class=\"tiny-share-widget\" data-id=\"3439779\" data-linked=\"Cowen sees 94% upside in Aurora Cannabis in premarket analyst action\" data-tweet=\"$ACB $GOSS $ALNY - Cowen sees 94% upside in Aurora Cannabis in premarket analyst action https://seekingalpha.com/news/3439779-cowen-sees-94-upside-in-aurora-cannabis-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3439779-cowen-sees-94-upside-in-aurora-cannabis-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439774\" data-ts=\"1551790231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BEST\" target=\"_blank\">BEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439774-bestplus-7-on-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BEST +7% on Q4 beats</a></h4><ul><li>BEST (NYSE:<a href='https://seekingalpha.com/symbol/BEST' title='Best, Inc.'>BEST</a>) <font color=\"green\">gains 7.4% </font>pre-market after Q4 beats with earnings of RMB 0.05 per share (consensus: 0.03 from a single analyst) and revenue of RMB 9.04B (consensus: 8.24B). Upside FY19 guidance has revenue from RMB 36.5B to 37.2B compared to the 35.14B consensus.</li><li><a href=\"https://seekingalpha.com/pr/17432818-best-inc-announces-unaudited-fourth-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Press release.</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3439702-best-reports-q4-results\" target=\"_blank\">BEST reports Q4 results</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439774\" data-linked=\"BEST +7% on Q4 beats\" data-tweet=\"$BEST - BEST +7% on Q4 beats https://seekingalpha.com/news/3439774-bestplus-7-on-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3439774-bestplus-7-on-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3439772\" data-ts=\"1551789929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMRX\" target=\"_blank\">CMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3439772-chimerixplus-3-on-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chimerix +3% on Q4 results</a></h4><ul><li>Chimerix (<a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix Inc'>CMRX</a>) <a href=\"https://seekingalpha.com/pr/17433014-chimerix-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 results</a>: Revenues: $4.9M (+172.2%).</li><li>Net Loss: ($15M) (+21.9%); Loss Per Share: ($0.29) (+29.3%); Quick Assets: $186.5M (+23.1%).</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439736-chimerix-beats-0_06-beats-revenue\" target=\"_blank\">Chimerix beats by $0.06, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3439772\" data-linked=\"Chimerix +3% on Q4 results\" data-tweet=\"$CMRX - Chimerix +3% on Q4 results https://seekingalpha.com/news/3439772-chimerixplus-3-on-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3439772-chimerixplus-3-on-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}